Bipolar Disorders Treatment Market Size and Competitive Analysis till 2031

Historic Data: 2021-2023   |   Base Year: 2024   |   Forecast Period: 2025-2031

Coverage: Bipolar Disorders Treatment Market covers analysis by Type (Bipolar I, Bipolar II, Cyclothymia); Medication (Lithium, Anticonvulsants, Antipsychotics, Antidepressants, Anti-anxiety medications); Treatment (ECT (Electroconvulsive therapy), TMS (Transcranial magnetic stimulation), Others (Psychotic therapies)) , and Geography (North America, Europe, Asia Pacific, and South and Central America)

  • Report Code : TIPRE00004415
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

MARKET INTRODUCTION


Bipolar disorder, also known as manic depression, is a type of mental health condition which is associated with mood swings. Mood swings/ episodes are of two types: manic and depressive. The changes in the mental health causes sudden high or low moods in a person. A person suffering from bipolar disorder or maniac depression can be joyful, happy, and energized or sad and hopeless at the very next moment. Through rigorous research and development activities, scientists have discovered that certain genes cause the bipolar disorder. Family history of bipolar disorder is one of the major reason that causes such illness. Such kind of mood swings can spoil the image of the person at a school or work place or in the society.

MARKET DYNAMICS


Growing awareness about diagnosis and treatment of bipolar disorder, increasing acceptance of society regarding mental illness, technological advancement bipolar disorder diagnosis and increase in treatment options for genetic disorders are major factors driving the bipolar disorder treatment market. Furthermore, government initiatives such as launch of Bipolar Disorder Phenome Database, funded by the National Institute of Mental Health (NIMH). These factors has further contributed to the growth of the market. However, factors such as stringent regulatory frameworks, side effects of anticonvulsants, and limited number of approved anticonvulsants for the treatment are few factors may restrain the growth of the market.

MARKET SCOPE


The "Global Bipolar Disorders Treatment Market Analysis to 2031" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of Bipolar Disorders Treatment market with detailed market segmentation by type, medication, treatment and geography. The global Bipolar Disorders Treatment market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Bipolar Disorders Treatment market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION


The global Bipolar Disorders Treatment market is segmented on the type, medication and treatment. On the basis of type, the global Bipolar Disorders Treatment market is segmented into Bipolar I, Bipolar II and Cyclothymia. On the basis of medication, the market is segmented into lithium, anticonvulsants, antipsychotics, antidepressants and anti-anxiety medications. On the basis of treatment, the bipolar disorder treatment market is segmented into ECT (Electroconvulsive therapy), TMS (Transcranial magnetic stimulation) and others (Psychotic therapies).
  • This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

REGIONAL FRAMEWORK


The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Bipolar Disorders Treatment market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Bipolar Disorders Treatment market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Bipolar Disorders Treatment market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Bipolar Disorders Treatment market in these regions.

  • This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

MARKET PLAYERS


The reports cover key developments in the Bipolar Disorders Treatment market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Bipolar Disorders Treatment market are anticipated to lucrative growth opportunities in the future with the rising demand for Bipolar Disorders Treatment in the global market. Below mentioned is the list of few companies engaged in the Bipolar Disorders Treatment market.

The report also includes the profiles of key Bipolar Disorders Treatment market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
  • AbbVie Inc.
  • AstraZeneca
  • Allergan Plc.
  • Bristol-Myers Squibb
  • Eli Lilly and Company
  • GlaxoSmithKline
  • Janssen Pharmaceuticals
  • Merck & Co., Inc.
  • Novartis AG
  • Pfizer Inc.
  • Otsuka Holdings Co. Ltd.
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

  • This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Bipolar Disorders Treatment Report Scope

Report Attribute Details
Market size in 2024 US$ XX million
Market Size by 2031 US$ XX Million
Global CAGR (2025 - 2031) XX%
Historical Data 2021-2023
Forecast period 2025-2031
Segments Covered By Type
  • Bipolar I
  • Bipolar II
  • Cyclothymia
By Medication
  • Lithium
  • Anticonvulsants
  • Antipsychotics
  • Antidepressants
  • Anti-anxiety medications
By Treatment
  • ECT
  • TMS
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • AbbVie Inc.
  • AstraZeneca
  • Allergan Plc.
  • Bristol-Myers Squibb
  • Eli Lilly and Company
  • GlaxoSmithKline
  • Janssen Pharmaceuticals
  • Merck & Co., Inc.
  • Novartis AG
    • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
    • PEST and SWOT Analysis
    • Market Size Value / Volume - Global, Regional, Country
    • Industry and Competitive Landscape
    • Excel Dataset
    bipolar-disorders-treatment-market-report-deliverables-img1
    bipolar-disorders-treatment-market-report-deliverables-img2
    Report Coverage

    Report Coverage

    Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

    Segment Covered

    Segment Covered

    This text is related
    to segments covered.

    Regional Scope

    Regional Scope

    North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

    Country Scope

    Country Scope

    This text is related
    to country scope.

    Trends and growth analysis reports related to Life Sciences : READ MORE..   

    Bipolar Disorders Treatment Market
    Connect With Expert
    The List of Companies

    1. AbbVie Inc.
    2. AstraZeneca
    3. Allergan Plc.
    4. Bristol-Myers Squibb
    5. Eli Lilly and Company
    6. GlaxoSmithKline
    7. Janssen Pharmaceuticals
    8. Merck & Co. , Inc.
    9. Novartis AG
    10. Pfizer Inc.
    11. Otsuka Holdings Co. Ltd.
    bipolar-disorders-treatment-market-cagr